RMD
Resmed Inc
$198.50
-5.37 (-2.63%)
At close · Jul 13
Market Cap
$28.79B
Shares
145,056,384
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$5.15B
+9.8%
FY2025
Net Income
$1.4B
+37.2%
FY2025
Gross Margin
59.36%
+2.7pp
FY2025
Operating Margin
32.75%
+4.6pp
FY2025
Diluted EPS
$9.51
+37.4%
FY2025
Operating Cash Flow
$1.75B
+25%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $5.54B | $5.15B | $4.69B | $4.22B | $3.58B | $3.2B | $2.96B | $2.61B | $2.34B | $2.07B | $1.84B | $1.68B | $1.55B | $1.51B | $1.37B | $1.24B | $1.09B | $920.74M | |
| -$54.73M | — | — | -$47.38M | -$22.31M | -$23.63M | -$39.36M | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | $90.08M | $93.43M | $87.87M | — | — | — | — | — | — | — | — | — | — | — | |
| $2.13B | $2.09B | $2.03B | $1.87B | $1.55B | $1.36B | $1.24B | $1.11B | $1.01B | $864.99M | $772.22M | $667.52M | $565.19M | $573.8M | $547.78M | $501.82M | $436.87M | $366.93M | |
| $3.41B | $3.05B | $2.66B | $2.36B | $2.02B | $1.84B | $1.72B | $1.49B | $1.33B | $1.2B | $1.07B | $1.01B | $989.79M | $940.66M | $820.74M | $741.33M | $655.48M | $553.8M | |
| — | 59.36% | 56.67% | 55.78% | 56.57% | 57.53% | 58.09% | 57.32% | 57.04% | 58.15% | 58% | 60.24% | 63.65% | 62.11% | 59.97% | 59.63% | 60.01% | 60.15% | |
| $359M | $331.28M | $307.53M | $287.64M | $253.58M | $225.28M | $201.95M | $180.65M | $155.15M | $144.47M | $118.65M | $114.87M | $118.23M | $120.12M | $109.73M | $92.01M | $75.2M | $63.06M | |
| $1.09B | $991.02M | $917.14M | $874M | $737.51M | $670.39M | $676.69M | $645.01M | $600.37M | $553.97M | $488.06M | $478.63M | $450.41M | $430.8M | $402.62M | $372.25M | $328.86M | $289.88M | |
| $32.85M | $32.12M | $32.96M | $30.4M | $39.65M | $45.13M | $49.6M | $42.51M | $27.27M | $46.6M | $30.2M | $15M | $15.9M | $17M | $13.97M | $10.15M | $8.04M | $7.06M | |
| $220.19M | $198.47M | $176.87M | $165.16M | $159.61M | $156.76M | $154.85M | $150.8M | $119.96M | $112.16M | $86.85M | $73.06M | $73.45M | $78.28M | $85.86M | $70.62M | $61.56M | $53.96M | |
| $21.75M | $0 | $64.23M | $9.18M | $0 | $8.67M | $0 | $9.4M | $18.43M | $12.36M | $6.91M | — | $6.33M | — | — | — | — | — | |
| $1.52B | $1.37B | $1.34B | $1.22B | $1.02B | $935.42M | $908.13M | $914.81M | $793.07M | $775.95M | $637.55M | $602.16M | $584.7M | $585.83M | $526.33M | $474.4M | $415.1M | $363.49M | |
| $1.89B | $1.69B | $1.32B | $1.13B | $1B | $903.68M | $809.66M | $579.26M | $541.83M | $425.8M | $428.95M | $409.24M | $405.09M | $354.82M | $294.41M | $266.92M | $240.38M | $190.31M | |
| — | 32.75% | 28.17% | 26.8% | 27.96% | 28.27% | 27.38% | 22.22% | 23.15% | 20.6% | 23.33% | 24.38% | 26.05% | 23.43% | 21.51% | 21.47% | 22.01% | 20.67% | |
| $2.11B | $1.88B | $1.5B | $1.3B | $1.16B | $1.06B | $964.51M | $730.06M | $661.79M | $537.96M | $515.8M | $482.29M | $478.54M | $433.1M | $380.26M | $337.54M | $301.95M | $244.27M | |
| $22.42M | — | — | — | — | $23.99M | $40.38M | $36.16M | $28.36M | $28.24M | $11.21M | $5.78M | $6.13M | $6.39M | $4.79M | $1.76M | $2.67M | — | |
| — | — | — | — | — | $362K | $1.02M | $2.3M | $16.38M | $17.09M | $16.86M | $26.21M | $31.24M | $38.87M | $33.87M | $27.8M | $16.7M | $10.21M | |
| $10.76M | -$7.8M | -$55.1M | -$30.21M | -$39.8M | -$20.02M | -$76.57M | -$60.42M | -$20.52M | -$7.06M | $10.61M | $26.68M | $25.99M | $30.3M | $37.54M | $36.78M | $20.21M | $11.37M | |
| $5.99M | $3.64M | -$1.85M | -$7.27M | -$8.49M | -$11.21M | -$25.06M | -$15.83M | — | — | — | — | — | — | — | — | — | — | |
| $1.9B | $1.68B | $1.26B | $1.1B | $960.48M | $883.66M | $733.09M | $518.85M | $521.31M | $418.74M | $439.57M | $435.92M | $431.08M | $385.12M | $331.95M | $303.71M | $260.59M | $201.68M | |
| $383.74M | $276.84M | $243.85M | $204.11M | $181.05M | $409.16M | $111.41M | $114.26M | $205.72M | $76.46M | $87.16M | $83.03M | $85.81M | $77.99M | $77.1M | $76.72M | $70.5M | $55.24M | |
| $1.52B | $1.4B | $1.02B | $897.56M | $779.44M | $474.51M | $621.67M | $404.59M | $315.59M | $342.28M | $352.41M | $352.89M | $345.27M | $307.13M | $254.85M | $226.99M | $190.09M | $146.45M | |
| — | 27.22% | 21.79% | 21.25% | 21.78% | 14.84% | 21.02% | 15.52% | 13.49% | 16.56% | 19.17% | 21.02% | 22.2% | 20.28% | 18.62% | 18.26% | 17.4% | 15.91% | |
| $1.75B | $1.58B | $1.04B | $937.78M | $660.18M | $565M | $590.7M | $375.91M | $280.32M | $375.88M | $303.27M | $27.81M | $404.74M | $162.77M | $166.87M | $465.04M | $86.38M | — | |
| USD/shares | — | $9.55 | $6.94 | $6.12 | $5.34 | $3.27 | $4.31 | $2.83 | $2.21 | $2.42 | $2.51 | $2.51 | $2.44 | $2.15 | $1.75 | $1.49 | $1.26 | $0.97 |
| USD/shares | — | $9.51 | $6.92 | $6.09 | $5.30 | $3.24 | $4.27 | $2.80 | $2.19 | $2.40 | $2.49 | $2.47 | $2.39 | $2.10 | $1.71 | $1.44 | $1.23 | $0.95 |
| shares | — | 146.72M | 147.02M | 146.77M | 146.07M | 145.31M | 144.34M | 143.11M | 142.76M | 141.36M | 140.24M | 140.47M | 141.47M | 142.95M | 145.9M | 152.47M | 150.91M | 151.26M |
| shares | — | 147.34M | 147.55M | 147.46M | 147.04M | 146.45M | 145.65M | 144.48M | 143.99M | 142.45M | 141.67M | 142.69M | 144.36M | 146.41M | 149.32M | 157.2M | 155.1M | 154.23M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $1.93B in buybacks, $2.71B in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Instruments & Supplies median 1.86×
EV/EBIT
—
Medical Instruments & Supplies median 31.50×
P/E (TTM)
19.14×
Medical Instruments & Supplies median 36.87×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 |
|---|---|---|---|---|---|---|---|---|
| Sleep and Breathing Health | $4,504,890,000 | $4,101,172,000 | $3,725,017,000 | — | — | — | — | — |
| Residential Care Software | $641,437,000 | $584,125,000 | $497,976,000 | — | — | — | — | — |
| Devices and Masks | — | — | — | — | $2,823,235,000 | $2,602,381,000 | $2,330,783,000 | $2,183,193,000 |
| Sleep and Respiratory | — | — | — | $3,177,298,000 | — | — | — | — |
| Software as a Service | — | — | — | $400,829,000 | $373,590,000 | — | — | — |
| Software as Service Before Deferred Revenue Adjustment | — | — | — | — | — | — | $281,137,000 | $157,003,000 |
| Software as Service | — | — | — | — | — | $354,632,000 | $275,789,000 | $157,003,000 |
By Geography (USD)
| Component | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 |
|---|---|---|---|---|---|---|---|---|
| United States | $3,285,581,000 | $2,980,053,000 | $2,719,923,000 | $2,249,381,000 | $1,962,721,000 | $1,828,575,000 | $1,588,655,000 | $1,345,212,000 |
| Rest of World | $1,860,746,000 | $1,705,244,000 | $1,503,070,000 | $1,328,746,000 | $1,234,104,000 | $1,128,438,000 | $1,017,917,000 | $994,984,000 |
| Global | — | — | — | $3,578,127,000 | $3,196,825,000 | $2,957,013,000 | $2,606,572,000 | $2,340,197,000 |
| U.S. Canada and Latin America | — | — | — | $2,382,636,000 | $2,078,703,000 | $1,926,959,000 | $1,696,285,000 | $1,447,086,000 |
By Product & Service (USD)
| Component | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 |
|---|---|---|---|---|---|---|---|---|
| Sleep and Breathing Health | $4,504,890,000 | $4,101,172,000 | $3,725,017,000 | — | — | — | — | — |
| Residential Care Software | $641,437,000 | $584,125,000 | $497,976,000 | — | — | — | — | — |
| Sleep and Respiratory | — | — | — | $3,177,298,000 | $2,823,235,000 | $2,602,381,000 | $2,330,783,000 | $2,183,193,000 |
| Software as a Service | — | — | — | $400,829,000 | $373,590,000 | — | — | — |
| Software as Service | — | — | — | — | — | $354,632,000 | $275,789,000 | $157,003,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 |
|---|---|---|---|---|---|---|---|---|
| Sleep and Breathing Health | $1,964,385,000 | $1,681,354,000 | $1,447,120,000 | — | — | — | — | — |
| Residential Care Software | $205,000,000 | $154,450,000 | $115,655,000 | — | — | — | — | — |
| Devices and Masks | — | — | $1,502,475,000 | $1,311,559,000 | $1,170,305,000 | $934,697,000 | $766,068,000 | $656,311,000 |
| Sleep and Respiratory | — | $1,681,354,000 | $1,447,120,000 | $1,279,591,000 | — | — | — | — |
| Software as a Service | — | $154,450,000 | $115,655,000 | $93,756,000 | $92,357,000 | — | — | — |
| Software as Service | — | — | — | $93,821,000 | $93,037,000 | $82,152,000 | $74,886,000 | $55,224,000 |
Operating Margin by Segment (%)
| Component | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 |
|---|---|---|---|---|---|---|---|---|
| Sleep and Breathing Health | 43.6% | 41% | 38.8% | — | — | — | — | — |
| Residential Care Software | 32% | 26.4% | 23.2% | — | — | — | — | — |
| Devices and Masks | — | — | — | — | 41.5% | 35.9% | 32.9% | 30.1% |
| Sleep and Respiratory | — | — | — | 40.3% | — | — | — | — |
| Software as a Service | — | — | — | 23.4% | 24.7% | — | — | — |
| Software as Service | — | — | — | — | — | 23.2% | 27.2% | 35.2% |
Key facts
CIK
943819
CUSIP
761152107
13F (30d)
74 filings
52 filers
Visit website
Investor relations